Leveraging HIV advancement in the light of Tuberculosis and Malaria using System Dynamics
Abstract
Chronic illnesses to which HIV/AIDS, Malaria and TB is part, have had long term direct impact on the population, social economic status as well as health in general. A lot of commitment by governments, non-governmental organizations, international organizations etc. intended to reduce mortality of these disease. These intentions have not had proportionate return on investment.This paper explores factors that influence the progression of HIV into AIDS with particular emphasis on opportunistic infections particularly malaria and TB. Although there has been tools and techniques geared towards study of these diseases many of them have been lacking systemic approach or fail to communicate to healthcare providers therefore rendering their efforts ineffective.The authors argue that the range of infectiousness in the population specifically HIV/AIDS, incidence of new cases and its progression including interventions ideally reduce mortality rate leaving more people living with the disease and requiring more care in the course of the disease. Living with the disease while still on medication awakens latent infections which go on unnoticed but the patient continues with the medication allowing these new infection to gain undue advantage of the immune system. With models to leverage realistic predictions and awareness, simultaneously allowing care delivery can unveil hidden trends in the disease under consideration.The descriptive model allows systematic inquiry that yields explanations and provides healthcare providers with common decision making platform. The authors further suggest triumvirate model of HIV, malaria and TB that utilizes system dynamics in a resource limited setting.
Keywords
Full Text:
PDFReferences
D. Ho, N. A.U, and P. A. S., “Rapid turnover of plasma virions and cd4 lymphocytes in hiv-1 infection,” Nature, vol. 373, pp. 123–126, 1995.
A. S. Perelson, E. A.U., and C. et al., “Decay characteristics of hiv-1 infected compartments during combination therapy,” Nature, vol. 387, pp. 188–191, 1997.
A. S. Perelson, A. Neumann, M. Markowitz, and et al., “Hiv-1 dynamics in vivo: virion clearance rate, infected cell life-span and viral generation,” Science, vol. 387, pp. 1582–1586, 1996.
S. Watanabe and Karhunen-Loeve Expansion and factor analysis theoretical remarks and applications, 1965.
S. Bonhoeffer, C. J. M., and N. M. A., “Human inmmunodeficiency virus drug therap and virus load,” J. Virol, vol. 3275-3278, p. 97, 1997.
S. Sharma, A. Mohan, and T. Kadhiravan, “Hiv-tb co-infection: Epidemiology, diagnosis and management,” Indian J.Med Res, vol. 121, pp. 550–567, 2005.
Y. D. Mukadi, D. Mahera, and A. Harries, “Tuberculosis case fatality rates in high hiv prevalence populations in sub-Saharan africa,” AIDS, vol. 15, pp. 143–152, 2001.
M. Laskowski, B. C. P. Demianyk, J. Witt, S. N. Mukhi, M. R. Friesen, and R. D. McLeod, “Agent-based modeling of the spread of influenza-like illness in an emergency department: A simulation study,” IEEE TRANSACTIONS ON INFORMATION TECHNOLOGY IN BIOMEDICINE, vol. 15, NO. 6, pp. 877–889, 2011.
A. S. Perelson and P. W. Nelson, “Mathematical analysis of hiv-1 dynamics in vivo,” Society for Industrial and Applied Mathematics, vol. 41 No. 1, p. 3–44, 1999.
Perelson, A. S. Kirschner, D. E. Boer, and ROBDE, “Dynamics of hiv of cd4+ infection t cells,” Mathematical Biosciences, vol. 125, 1993.
M. A. Nowak and R. M. May, “Mathematical biology of hiv infections: antigens variation and diversity threshold,” Mathematical Biosciences, vol. 106, pp. 1–21, 1991.
L. N. Cooper, “Theory of an immune system retrovirus,” National Academic Sciences, 1986.
R. Anderson and R. M. May, “The dynamics of microparasites and the invertebrate hosts,” vol. Royal Society 291, pp. 451–524, 1981.
B. Adams, H. Banks, M. Davidian, H.-D. Kwon, H. T. Tran, and S. N.Wayne, “Hiv dynamics: Modeling, data analysis, and optimal treatment protocols,” 2004.
B. Sally and H. Nicola, “A comparison of discrete event simulation and system dynamics for modelling healthcare systems,” pp. 1–17, 2006.
R. G. Wilkinson and M. Marmot, “The social determinants of health: The solid facts (denmark: World health organization),” 2003.
J. Sterman, “System thinking and modeling for a complex world,” Business Dynamics, 2000.
C. Copley, A. Parsons, S. Posnik, A. McCallum, and D. Knight, Good Practice Guidance on HIV/AIDS, Tuberculosis and Malaria. International Council on Mining and Metals (ICMM), London, UK, 2008.
Pedamallu, C. S. Ozdamar, L. Kropat, E.Weber, and Gerhard-Wilhelm, “A system dynamics model for intentional transmission of hiv/aids using cross impact analysis,” Central European Journal of Operations Research, vol. 3, pp. 319–336, 2010.
B. Sathian, “Statistical modelling of hiv/aids in nepal: A necessary enquiry,” Nepal Journal of Epidemiology, vol. 1(3), pp. 74–76, 2011.
J. A. Salomon, E. E. Gakidou, and C. J. Murray, “Methods for modeling the hiv/aids epidemic in sub-saharan africa.” GPE Discussion Paper Series: No. 3.
A. K. Abbas, A. H. Lichtman, and S. Pillai, Basic Immunology: Functions and Disorders of the Immune System. Elsevier, 2012.
V. S. Yadavalli, S. Udayabaskaran, M. M. Labeodan, and Y. Mwanga, “A stochastic model of the dynamics of hiv under a combination theraeutic intervention,” NR, vol. 25, pp. 17–30, 2009.
X. Wei, S. Ghosh, T. M.E, J. V.A, E. E.A, D. P, L. J.D, B. S, N. M.A, H. B.H, S. M.S, and S. G.M, “Viral dynamics in human immunodeficiency virus type 1 infection,” Nature, vol. 373, pp. 117–122, 1995.
M. Nijhuis, B. C.A.B, S. P, L. T, S. R, and A. J, “Stochastic prprocess strongly influence hiv-1 evolution during suboptimal protease inhibitor therapy,” Nation Academic of Science Proceedings, vol. 179, pp. 14441–14446, 1998.
Z. Mukandavire, A. B. Gumel, W. Garira, and J. M. Tchuenche, “Mathematical analysis of a model for hiv-malaria co-infection,” Mathematical Biosciences and Engineering, vol. 6-2, pp. 333–362, 2009.
U. Shankarkumar, A. Shankarkumar, and K. Ghosh, “Hiv and malaria co-infection in mumbai, western india,” Vector Borne and Zoonotic Diseases, vol. 48, pp. 155–158, 2011.
E. Amuta, H. R. ., and A. Diya, “Malarial infection among hiv patients on antiretroviral therapy (art) and not on art: a case study of federal medical centre makurdi, benue state, nigeria,” Asian Pacific Journal of Tropical Biomedicine, 2012.
N. Bailey, “The bioinformatics of malaria,” 1982.
E. L. Korenromp, B. G. Williams, S. J. de Vlas, and E. Gouws, “Malaria attribute to the hiv-1 epidemic, sub-saharan africa,” Emerging Infectious Diseases, vol. 11, 2005.
A. Tkachuk, M. AM, P. JA, R. RA, C. SW, and M. V. et al, “Malaria enhances expression of cc chemokine receptor 5 on placental macrophages,” Infectious Disease, vol. 183, pp. 1603–7, 2001.
T. Gustafsson, “Expert consultation in the preparation of a national technology programme,” Systems Analysis Laboratory, Helsinki University of Technology, 2003.
D. Mildvan, “An approach to the validation of markers for use in aids clinical trials,” Clinical Infectious Diseases,vol. 24, pp. 764–774, 1997.
D. W. Williams, “Dynamic synthesis: A theoretical framework for research in requirements engineering process management,” Operational Research Society, ISBN: 0 903440202., 2000.